Papers
2
Total Citations
81
H-Index
2
About
Xiaofei Ye is a leading researcher in the field of minimally invasive surgical oncology, with a primary focus on robotic-assisted and laparoscopic techniques for complex urologic and gastrointestinal cancers. Ye’s major contributions lie in providing high-level evidence through rigorous systematic reviews and meta-analyses, particularly in comparing the efficacy and safety of robotic versus laparoscopic approaches. Their landmark 2023 study on robotic-assisted versus laparoscopic radical prostatectomy, which has garnered 49 citations, was the first to separately analyze randomized and non-randomized trials, offering crucial clarity in a previously debated area. Additionally, Ye’s 2022 single-center retrospective study on robotic pancreatoduodenectomy, with 32 citations, has advanced the understanding of robotic surgery’s feasibility and safety for pancreatic cancer, a notoriously challenging procedure. By systematically evaluating perioperative outcomes, Ye has helped guide clinical decision-making and surgical innovation. Their work is highly cited and influential, reflecting a commitment to evidence-based surgery that directly impacts patient care and surgical practice. Ye’s research continues to shape the landscape of robotic surgery, making them a key voice in the evolution of modern surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2